Skip to main content
Clinical Trials/ChiCTR-IPC-15006212
ChiCTR-IPC-15006212RecruitingPhase 1

盐酸右美托咪定单独用于妇科腹腔镜术后镇痛的研究

Not provided1 site in 1 country60 target enrollmentStarted: April 7, 2015Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Enrollment
60
Locations
1
Primary Endpoint
视觉模拟镇痛评分

Study Overview

Brief Summary

观察盐酸右美托咪定用于妇科腹腔镜术后镇痛效果

Study Design

Study Type
Interventional
Primary Purpose
横断面

Eligibility Criteria

Ages
20 to 60 (—)
Sex
Female

Inclusion Criteria

  • 拟行妇科腹腔镜手术的病人,年龄 20-60 岁,ASA 分级Ⅰ–Ⅱ纳入本次研究

Exclusion Criteria

  • 有严重肺部疾病,心功能不全(左室射血分数< 40%),或体重指数> 35 kg m-2,长期阿片类药物或非甾体类消炎镇痛药物、镇静药物使用史,精神失常,心动过缓心脏传导或心室率异常的病人经排除在外。如果病人由于某种原因需转开腹手术,或由于术后出血等原因需再次手术者也剔除本研究。

Arms & Interventions

安慰剂组

生理盐水

右美托咪定组

右美托咪定镇痛

芬太尼组

芬太尼镇痛

Outcomes

Primary Outcomes

视觉模拟镇痛评分

清醒 / 镇静评分

Secondary Outcomes

  • 病人满意度
  • 恶心、呕吐、呼吸抑制
  • 胃肠道功能恢复情况

Investigators

Study Sites (1)

Loading locations...

Similar Trials